This is a cohort study performed in patients with cardiovascular diaeases who were treated with oral Chinese medicine and Western medicine. Collect indicators such as the incidence of cardiovascular events, all due to readmission, all due to death. To hospital using clinical samples to detect genomics, proteomics, metabolomics, intestinal flora and sclerotia.To explore the clinical efficacy of Chinese patent medicine in the treatment of cardiovascular diseases, and provide reliable data support for its clinical application.
Study Type
OBSERVATIONAL
Enrollment
20,000
Shexiang Baoxin Pill, Tongxinluo Capsule, Tongmai Yangxin Pill, Xuefu Zhuyu Capsule, Qishen Yiqi Dropping Pill, etc.
Tianjin University of Traditional Chinese Medicine
Tianjin, China
RECRUITINGCardiovascular Events Cardiovascular Events Cardiovascular Events
Non-fatal myocardial infarction, non-fatal ischemic stroke, unplanned hemodynamic reconstruction.
Time frame: one year
All due to readmission
Readmission for cardiovascular events and readmission for other reasons.
Time frame: one year
All due to death
Cardiac death and death from other causes.
Time frame: one year
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.